Although this contrasts with our previous report describing a pro-leukemic role for miR-196b in already established DNMT3A/FLT3-mutant AML [7], a similar dichotomy was revealed for miR-196b in MLL-r AML [13]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.